2. Search Result
Search Result
Results for "

2-Chloro-N6-cyclopentyladenosine hemihydrate

" in MedChemExpress (MCE) Product Catalog:

4

阻害剤およびアゴニスト

1

オリゴヌクレオチド

製品番号 製品名 Target 研究分野 構造式
  • HY-103185
    CCPA
    1 Publications Verification

    2-Chloro-N6-cyclopentyladenosine

    		 Adenosine Receptor Adenylate Cyclase Cardiovascular Disease Neurological Disease
    CCPA (2-Chloro-N6-cyclopentyladenosine) a highly selective A1 adenosine receptors agonist with a Ki of 0.4 nM. CCPA inhibits adenylate cyclase with an IC50 of 33 nM. CCPA exhibits anti-seizure and cardiacprotective activity. CCPA can be used for the research of seizure and myocardial infarction .
    CCPA
  • HY-103185R
    CCPA (Standard)

    2-Chloro-N6-cyclopentyladenosine (Standard)

    		 Reference Standards Adenosine Receptor Adenylate Cyclase Cardiovascular Disease Neurological Disease
    CCPA (2-Chloro-N6-cyclopentyladenosine (Standard)) is the analytical standard of CCPA (HY-103185). This product is intended for research and analytical applications. CCPA (2-Chloro-N6-cyclopentyladenosine) a highly selective A1 adenosine receptors agonist with a Ki of 0.4 nM. CCPA inhibits adenylate cyclase with an IC50 of 33 nM. CCPA exhibits anti-seizure and cardiacprotective activity. CCPA can be used for the research of seizure and myocardial infarction .
    CCPA (Standard)
  • HY-103185A
    CCPA hemihydrate

    2-Chloro-N6-cyclopentyladenosine hemihydrate

    		 Adenosine Receptor Adenylate Cyclase Cardiovascular Disease Neurological Disease
    CCPA (2-Chloro-N6-cyclopentyladenosine) hemihydrate a highly selective A1 adenosine receptors agonist with a Ki of 0.4 nM. CCPA hemihydrate inhibits adenylate cyclase with an IC50 of 33 nM. CCPA hemihydrate exhibits anti-seizure and cardiacprotective activity. CCPA hemihydrate can be used for the research of seizure and myocardial infarction .
    CCPA hemihydrate
  • HY-112567
    TRR469

    		Adenosine Receptor Neurological Disease
    TRR469 is a positive allosteric modulator of the A1 adenosine receptor (A1AR). TRR469 significantly increases the affinity of 2-chloro N(6)-cyclopentyladenosine (CCPA) for A₁AR, increasing the number of receptors recognized by the agonist radioligand [³H]-CCPA. TRR469 shows significant effects in both anxiety and pain models. TRR469 can be used to study anxiety disorders and pain management .
    TRR469

オンラインお問い合わせ

入力情報は安全に管理されます. ※ 必須入力項目.

タイトル

  

国或いは地域 *

お名前 *

 

組纖名 *

デパートメント *

     

メールアドレス *

 

製品名 *

製品番号

  

カスタマ需要量 *

電話番号 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
製品番号:
数量:
MCE 日本正規代理店: